Pharmacy Focus: Oncology Edition - A Conversation About Biden's Cancer Moonshot Program

cancerHHSlife scienceshealthcarePharmacy Times
Written By Ron Lanton

In the first episode of Pharmacy Focus: Oncology Edition, the Times spoke with Ron Lanton, JD, principal at Lanton Law. Although it is still too early to know how the program differs from private-sector efforts to improve cancer treatments, Lanton said the program has some interesting goals and approaches.

The podcast can be heard here.

Ron Lanton
Previous

FDA Releases Draft Cybersecurity Guidance

Next

CMS is Proposing to Delay the Radiation Oncology (RO) Model